Details of the Drug

General Information of Drug (ID: DMWIEC1)

Drug Name
OTSA-101-DTPA-90Y
Indication
Disease Entry ICD 11 Status REF
Synovial sarcoma 2B5A Phase 1 [1]
Drug Type
Antibody
Cross-matching ID
TTD ID
D1ZG5E

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Frizzled-10 (FZD10) TTP1S2F FZD10_HUMAN Not Available [2]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 ClinicalTrials.gov (NCT01469975) First in Man Study Investigating the Biodistribution, the Safety and Optimal Recommended Dose of a New Radiolabelled Monoclonal Antibody Targeting Frizzled Homolog 10 (SYNFRIZZ). U.S. National Institutes of Health.
2 A first-in-human study investigating biodistribution, safety and recommended dose of a new radiolabeled MAb targeting FZD10 in metastatic synovial sarcoma patients. BMC Cancer. 2018 Jun 8;18(1):646.